ペプチド核酸のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Peptide Nucleic Acid Market Insights and Forecast to 2028

• レポートコード：QY2203B05997 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のペプチド核酸の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にペプチド核酸の世界市場のxxx％を占める「ダブルチェーン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「ジーンチップ」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のペプチド核酸の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのペプチド核酸市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのペプチド核酸市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ペプチド核酸のグローバル主要メーカーには、Abbott Molecular、PerkinElmer、SciGene Corporation、Roche NimbleGen、CytoTestなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ペプチド核酸市場は、種類と用途によって区分されます。世界のペプチド核酸市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ダブルチェーン、シングルチェーン 【用途別セグメント】 ジーンチップ、電気泳動、蛍光in situハイブリダイゼーション 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ペプチド核酸製品概要 - 種類別市場（ダブルチェーン、シングルチェーン） - 用途別市場（ジーンチップ、電気泳動、蛍光in situハイブリダイゼーション） - 調査の目的 ・エグゼクティブサマリー - 世界のペプチド核酸販売量予測2017-2028 - 世界のペプチド核酸売上予測2017-2028 - ペプチド核酸の地域別販売量 - ペプチド核酸の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ペプチド核酸販売量 - 主要メーカー別ペプチド核酸売上 - 主要メーカー別ペプチド核酸価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ダブルチェーン、シングルチェーン） - ペプチド核酸の種類別販売量 - ペプチド核酸の種類別売上 - ペプチド核酸の種類別価格 ・用途別市場規模（ジーンチップ、電気泳動、蛍光in situハイブリダイゼーション） - ペプチド核酸の用途別販売量 - ペプチド核酸の用途別売上 - ペプチド核酸の用途別価格 ・北米市場 - 北米のペプチド核酸市場規模（種類別、用途別） - 主要国別のペプチド核酸市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのペプチド核酸市場規模（種類別、用途別） - 主要国別のペプチド核酸市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のペプチド核酸市場規模（種類別、用途別） - 主要国別のペプチド核酸市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のペプチド核酸市場規模（種類別、用途別） - 主要国別のペプチド核酸市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのペプチド核酸市場規模（種類別、用途別） - 主要国別のペプチド核酸市場規模（トルコ、サウジアラビア） ・企業情報 Abbott Molecular、PerkinElmer、SciGene Corporation、Roche NimbleGen、CytoTest ・産業チェーン及び販売チャネル分析 - ペプチド核酸の産業チェーン分析 - ペプチド核酸の原材料 - ペプチド核酸の生産プロセス - ペプチド核酸の販売及びマーケティング - ペプチド核酸の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ペプチド核酸の産業動向 - ペプチド核酸のマーケットドライバー - ペプチド核酸の課題 - ペプチド核酸の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Peptide Nucleic Acid Market
Due to the COVID-19 pandemic, the global Peptide Nucleic Acid market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Double Chain accounting for % of the Peptide Nucleic Acid global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Gene Chip segment is altered to an % CAGR throughout this forecast period.
China Peptide Nucleic Acid market size is valued at US$ million in 2021, while the US and Europe Peptide Nucleic Acid are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Peptide Nucleic Acid landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Peptide Nucleic Acid include Abbott Molecular, PerkinElmer, SciGene Corporation, Roche NimbleGen and CytoTest, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Peptide Nucleic Acid capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Peptide Nucleic Acid by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Peptide Nucleic Acid Scope and Segment
Peptide Nucleic Acid market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Peptide Nucleic Acid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Double Chain
Single Chain
Segment by Application
Gene Chip
Electrophoresis
Fluorescence In Situ Hybridization
By Company
Abbott Molecular
PerkinElmer
SciGene Corporation
Roche NimbleGen
CytoTest
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Peptide Nucleic Acid Product Introduction
1.2 Market by Type
1.2.1 Global Peptide Nucleic Acid Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Double Chain
1.2.3 Single Chain
1.3 Market by Application
1.3.1 Global Peptide Nucleic Acid Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Gene Chip
1.3.3 Electrophoresis
1.3.4 Fluorescence In Situ Hybridization
1.4 Study Objectives
1.5 Years Considered
2 Global Peptide Nucleic Acid Production
2.1 Global Peptide Nucleic Acid Production Capacity (2017-2028)
2.2 Global Peptide Nucleic Acid Production by Region: 2017 VS 2021 VS 2028
2.3 Global Peptide Nucleic Acid Production by Region
2.3.1 Global Peptide Nucleic Acid Historic Production by Region (2017-2022)
2.3.2 Global Peptide Nucleic Acid Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Peptide Nucleic Acid Sales in Volume & Value Estimates and Forecasts
3.1 Global Peptide Nucleic Acid Sales Estimates and Forecasts 2017-2028
3.2 Global Peptide Nucleic Acid Revenue Estimates and Forecasts 2017-2028
3.3 Global Peptide Nucleic Acid Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Peptide Nucleic Acid Sales by Region
3.4.1 Global Peptide Nucleic Acid Sales by Region (2017-2022)
3.4.2 Global Sales Peptide Nucleic Acid by Region (2023-2028)
3.5 Global Peptide Nucleic Acid Revenue by Region
3.5.1 Global Peptide Nucleic Acid Revenue by Region (2017-2022)
3.5.2 Global Peptide Nucleic Acid Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Peptide Nucleic Acid Production Capacity by Manufacturers
4.2 Global Peptide Nucleic Acid Sales by Manufacturers
4.2.1 Global Peptide Nucleic Acid Sales by Manufacturers (2017-2022)
4.2.2 Global Peptide Nucleic Acid Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Peptide Nucleic Acid in 2021
4.3 Global Peptide Nucleic Acid Revenue by Manufacturers
4.3.1 Global Peptide Nucleic Acid Revenue by Manufacturers (2017-2022)
4.3.2 Global Peptide Nucleic Acid Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Peptide Nucleic Acid Revenue in 2021
4.4 Global Peptide Nucleic Acid Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Peptide Nucleic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Peptide Nucleic Acid Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Peptide Nucleic Acid Sales by Type
5.1.1 Global Peptide Nucleic Acid Historical Sales by Type (2017-2022)
5.1.2 Global Peptide Nucleic Acid Forecasted Sales by Type (2023-2028)
5.1.3 Global Peptide Nucleic Acid Sales Market Share by Type (2017-2028)
5.2 Global Peptide Nucleic Acid Revenue by Type
5.2.1 Global Peptide Nucleic Acid Historical Revenue by Type (2017-2022)
5.2.2 Global Peptide Nucleic Acid Forecasted Revenue by Type (2023-2028)
5.2.3 Global Peptide Nucleic Acid Revenue Market Share by Type (2017-2028)
5.3 Global Peptide Nucleic Acid Price by Type
5.3.1 Global Peptide Nucleic Acid Price by Type (2017-2022)
5.3.2 Global Peptide Nucleic Acid Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Peptide Nucleic Acid Sales by Application
6.1.1 Global Peptide Nucleic Acid Historical Sales by Application (2017-2022)
6.1.2 Global Peptide Nucleic Acid Forecasted Sales by Application (2023-2028)
6.1.3 Global Peptide Nucleic Acid Sales Market Share by Application (2017-2028)
6.2 Global Peptide Nucleic Acid Revenue by Application
6.2.1 Global Peptide Nucleic Acid Historical Revenue by Application (2017-2022)
6.2.2 Global Peptide Nucleic Acid Forecasted Revenue by Application (2023-2028)
6.2.3 Global Peptide Nucleic Acid Revenue Market Share by Application (2017-2028)
6.3 Global Peptide Nucleic Acid Price by Application
6.3.1 Global Peptide Nucleic Acid Price by Application (2017-2022)
6.3.2 Global Peptide Nucleic Acid Price Forecast by Application (2023-2028)
7 North America
7.1 North America Peptide Nucleic Acid Market Size by Type
7.1.1 North America Peptide Nucleic Acid Sales by Type (2017-2028)
7.1.2 North America Peptide Nucleic Acid Revenue by Type (2017-2028)
7.2 North America Peptide Nucleic Acid Market Size by Application
7.2.1 North America Peptide Nucleic Acid Sales by Application (2017-2028)
7.2.2 North America Peptide Nucleic Acid Revenue by Application (2017-2028)
7.3 North America Peptide Nucleic Acid Sales by Country
7.3.1 North America Peptide Nucleic Acid Sales by Country (2017-2028)
7.3.2 North America Peptide Nucleic Acid Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Peptide Nucleic Acid Market Size by Type
8.1.1 Europe Peptide Nucleic Acid Sales by Type (2017-2028)
8.1.2 Europe Peptide Nucleic Acid Revenue by Type (2017-2028)
8.2 Europe Peptide Nucleic Acid Market Size by Application
8.2.1 Europe Peptide Nucleic Acid Sales by Application (2017-2028)
8.2.2 Europe Peptide Nucleic Acid Revenue by Application (2017-2028)
8.3 Europe Peptide Nucleic Acid Sales by Country
8.3.1 Europe Peptide Nucleic Acid Sales by Country (2017-2028)
8.3.2 Europe Peptide Nucleic Acid Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Peptide Nucleic Acid Market Size by Type
9.1.1 Asia Pacific Peptide Nucleic Acid Sales by Type (2017-2028)
9.1.2 Asia Pacific Peptide Nucleic Acid Revenue by Type (2017-2028)
9.2 Asia Pacific Peptide Nucleic Acid Market Size by Application
9.2.1 Asia Pacific Peptide Nucleic Acid Sales by Application (2017-2028)
9.2.2 Asia Pacific Peptide Nucleic Acid Revenue by Application (2017-2028)
9.3 Asia Pacific Peptide Nucleic Acid Sales by Region
9.3.1 Asia Pacific Peptide Nucleic Acid Sales by Region (2017-2028)
9.3.2 Asia Pacific Peptide Nucleic Acid Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Peptide Nucleic Acid Market Size by Type
10.1.1 Latin America Peptide Nucleic Acid Sales by Type (2017-2028)
10.1.2 Latin America Peptide Nucleic Acid Revenue by Type (2017-2028)
10.2 Latin America Peptide Nucleic Acid Market Size by Application
10.2.1 Latin America Peptide Nucleic Acid Sales by Application (2017-2028)
10.2.2 Latin America Peptide Nucleic Acid Revenue by Application (2017-2028)
10.3 Latin America Peptide Nucleic Acid Sales by Country
10.3.1 Latin America Peptide Nucleic Acid Sales by Country (2017-2028)
10.3.2 Latin America Peptide Nucleic Acid Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Peptide Nucleic Acid Market Size by Type
11.1.1 Middle East and Africa Peptide Nucleic Acid Sales by Type (2017-2028)
11.1.2 Middle East and Africa Peptide Nucleic Acid Revenue by Type (2017-2028)
11.2 Middle East and Africa Peptide Nucleic Acid Market Size by Application
11.2.1 Middle East and Africa Peptide Nucleic Acid Sales by Application (2017-2028)
11.2.2 Middle East and Africa Peptide Nucleic Acid Revenue by Application (2017-2028)
11.3 Middle East and Africa Peptide Nucleic Acid Sales by Country
11.3.1 Middle East and Africa Peptide Nucleic Acid Sales by Country (2017-2028)
11.3.2 Middle East and Africa Peptide Nucleic Acid Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Abbott Molecular
12.1.1 Abbott Molecular Corporation Information
12.1.2 Abbott Molecular Overview
12.1.3 Abbott Molecular Peptide Nucleic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Abbott Molecular Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Abbott Molecular Recent Developments
12.2 PerkinElmer
12.2.1 PerkinElmer Corporation Information
12.2.2 PerkinElmer Overview
12.2.3 PerkinElmer Peptide Nucleic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 PerkinElmer Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 PerkinElmer Recent Developments
12.3 SciGene Corporation
12.3.1 SciGene Corporation Corporation Information
12.3.2 SciGene Corporation Overview
12.3.3 SciGene Corporation Peptide Nucleic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 SciGene Corporation Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 SciGene Corporation Recent Developments
12.4 Roche NimbleGen
12.4.1 Roche NimbleGen Corporation Information
12.4.2 Roche NimbleGen Overview
12.4.3 Roche NimbleGen Peptide Nucleic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Roche NimbleGen Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Roche NimbleGen Recent Developments
12.5 CytoTest
12.5.1 CytoTest Corporation Information
12.5.2 CytoTest Overview
12.5.3 CytoTest Peptide Nucleic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 CytoTest Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 CytoTest Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Peptide Nucleic Acid Industry Chain Analysis
13.2 Peptide Nucleic Acid Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Peptide Nucleic Acid Production Mode & Process
13.4 Peptide Nucleic Acid Sales and Marketing
13.4.1 Peptide Nucleic Acid Sales Channels
13.4.2 Peptide Nucleic Acid Distributors
13.5 Peptide Nucleic Acid Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Peptide Nucleic Acid Industry Trends
14.2 Peptide Nucleic Acid Market Drivers
14.3 Peptide Nucleic Acid Market Challenges
14.4 Peptide Nucleic Acid Market Restraints
15 Key Finding in The Global Peptide Nucleic Acid Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Peptide Nucleic Acid Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Double Chain
Table 3. Major Manufacturers of Single Chain
Table 4. Global Peptide Nucleic Acid Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Peptide Nucleic Acid Production by Region: 2017 VS 2021 VS 2028 (K MT)
Table 6. Global Peptide Nucleic Acid Production by Region (2017-2022) & (K MT)
Table 7. Global Peptide Nucleic Acid Production Market Share by Region (2017-2022)
Table 8. Global Peptide Nucleic Acid Production by Region (2023-2028) & (K MT)
Table 9. Global Peptide Nucleic Acid Production Market Share by Region (2023-2028)
Table 10. Global Peptide Nucleic Acid Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Peptide Nucleic Acid Sales by Region (2017-2022) & (K MT)
Table 12. Global Peptide Nucleic Acid Sales Market Share by Region (2017-2022)
Table 13. Global Peptide Nucleic Acid Sales by Region (2023-2028) & (K MT)
Table 14. Global Peptide Nucleic Acid Sales Market Share by Region (2023-2028)
Table 15. Global Peptide Nucleic Acid Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Peptide Nucleic Acid Revenue Market Share by Region (2017-2022)
Table 17. Global Peptide Nucleic Acid Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Peptide Nucleic Acid Revenue Market Share by Region (2023-2028)
Table 19. Global Peptide Nucleic Acid Production Capacity by Manufacturers (2017-2022) & (K MT)
Table 20. Global Peptide Nucleic Acid Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Peptide Nucleic Acid Sales by Manufacturers (2017-2022) & (K MT)
Table 22. Global Peptide Nucleic Acid Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Peptide Nucleic Acid Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Peptide Nucleic Acid Revenue Share by Manufacturers (2017-2022)
Table 25. Peptide Nucleic Acid Price by Manufacturers 2017-2022 (USD/MT)
Table 26. Global Peptide Nucleic Acid Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Peptide Nucleic Acid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Nucleic Acid as of 2021)
Table 28. Peptide Nucleic Acid Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Peptide Nucleic Acid Product Offered
Table 30. Date of Manufacturers Enter into Peptide Nucleic Acid Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Peptide Nucleic Acid Sales by Type (2017-2022) & (K MT)
Table 33. Global Peptide Nucleic Acid Sales by Type (2023-2028) & (K MT)
Table 34. Global Peptide Nucleic Acid Sales Share by Type (2017-2022)
Table 35. Global Peptide Nucleic Acid Sales Share by Type (2023-2028)
Table 36. Global Peptide Nucleic Acid Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Peptide Nucleic Acid Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Peptide Nucleic Acid Revenue Share by Type (2017-2022)
Table 39. Global Peptide Nucleic Acid Revenue Share by Type (2023-2028)
Table 40. Peptide Nucleic Acid Price by Type (2017-2022) & (USD/MT)
Table 41. Global Peptide Nucleic Acid Price Forecast by Type (2023-2028) & (USD/MT)
Table 42. Global Peptide Nucleic Acid Sales by Application (2017-2022) & (K MT)
Table 43. Global Peptide Nucleic Acid Sales by Application (2023-2028) & (K MT)
Table 44. Global Peptide Nucleic Acid Sales Share by Application (2017-2022)
Table 45. Global Peptide Nucleic Acid Sales Share by Application (2023-2028)
Table 46. Global Peptide Nucleic Acid Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Peptide Nucleic Acid Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Peptide Nucleic Acid Revenue Share by Application (2017-2022)
Table 49. Global Peptide Nucleic Acid Revenue Share by Application (2023-2028)
Table 50. Peptide Nucleic Acid Price by Application (2017-2022) & (USD/MT)
Table 51. Global Peptide Nucleic Acid Price Forecast by Application (2023-2028) & (USD/MT)
Table 52. North America Peptide Nucleic Acid Sales by Type (2017-2022) & (K MT)
Table 53. North America Peptide Nucleic Acid Sales by Type (2023-2028) & (K MT)
Table 54. North America Peptide Nucleic Acid Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Peptide Nucleic Acid Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Peptide Nucleic Acid Sales by Application (2017-2022) & (K MT)
Table 57. North America Peptide Nucleic Acid Sales by Application (2023-2028) & (K MT)
Table 58. North America Peptide Nucleic Acid Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Peptide Nucleic Acid Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Peptide Nucleic Acid Sales by Country (2017-2022) & (K MT)
Table 61. North America Peptide Nucleic Acid Sales by Country (2023-2028) & (K MT)
Table 62. North America Peptide Nucleic Acid Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Peptide Nucleic Acid Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Peptide Nucleic Acid Sales by Type (2017-2022) & (K MT)
Table 65. Europe Peptide Nucleic Acid Sales by Type (2023-2028) & (K MT)
Table 66. Europe Peptide Nucleic Acid Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Peptide Nucleic Acid Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Peptide Nucleic Acid Sales by Application (2017-2022) & (K MT)
Table 69. Europe Peptide Nucleic Acid Sales by Application (2023-2028) & (K MT)
Table 70. Europe Peptide Nucleic Acid Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Peptide Nucleic Acid Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Peptide Nucleic Acid Sales by Country (2017-2022) & (K MT)
Table 73. Europe Peptide Nucleic Acid Sales by Country (2023-2028) & (K MT)
Table 74. Europe Peptide Nucleic Acid Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Peptide Nucleic Acid Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Peptide Nucleic Acid Sales by Type (2017-2022) & (K MT)
Table 77. Asia Pacific Peptide Nucleic Acid Sales by Type (2023-2028) & (K MT)
Table 78. Asia Pacific Peptide Nucleic Acid Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Peptide Nucleic Acid Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Peptide Nucleic Acid Sales by Application (2017-2022) & (K MT)
Table 81. Asia Pacific Peptide Nucleic Acid Sales by Application (2023-2028) & (K MT)
Table 82. Asia Pacific Peptide Nucleic Acid Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Peptide Nucleic Acid Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Peptide Nucleic Acid Sales by Region (2017-2022) & (K MT)
Table 85. Asia Pacific Peptide Nucleic Acid Sales by Region (2023-2028) & (K MT)
Table 86. Asia Pacific Peptide Nucleic Acid Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Peptide Nucleic Acid Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Peptide Nucleic Acid Sales by Type (2017-2022) & (K MT)
Table 89. Latin America Peptide Nucleic Acid Sales by Type (2023-2028) & (K MT)
Table 90. Latin America Peptide Nucleic Acid Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Peptide Nucleic Acid Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Peptide Nucleic Acid Sales by Application (2017-2022) & (K MT)
Table 93. Latin America Peptide Nucleic Acid Sales by Application (2023-2028) & (K MT)
Table 94. Latin America Peptide Nucleic Acid Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Peptide Nucleic Acid Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Peptide Nucleic Acid Sales by Country (2017-2022) & (K MT)
Table 97. Latin America Peptide Nucleic Acid Sales by Country (2023-2028) & (K MT)
Table 98. Latin America Peptide Nucleic Acid Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Peptide Nucleic Acid Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Peptide Nucleic Acid Sales by Type (2017-2022) & (K MT)
Table 101. Middle East and Africa Peptide Nucleic Acid Sales by Type (2023-2028) & (K MT)
Table 102. Middle East and Africa Peptide Nucleic Acid Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Peptide Nucleic Acid Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Peptide Nucleic Acid Sales by Application (2017-2022) & (K MT)
Table 105. Middle East and Africa Peptide Nucleic Acid Sales by Application (2023-2028) & (K MT)
Table 106. Middle East and Africa Peptide Nucleic Acid Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Peptide Nucleic Acid Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Peptide Nucleic Acid Sales by Country (2017-2022) & (K MT)
Table 109. Middle East and Africa Peptide Nucleic Acid Sales by Country (2023-2028) & (K MT)
Table 110. Middle East and Africa Peptide Nucleic Acid Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Peptide Nucleic Acid Revenue by Country (2023-2028) & (US$ Million)
Table 112. Abbott Molecular Corporation Information
Table 113. Abbott Molecular Description and Major Businesses
Table 114. Abbott Molecular Peptide Nucleic Acid Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. Abbott Molecular Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Abbott Molecular Recent Development
Table 117. PerkinElmer Corporation Information
Table 118. PerkinElmer Description and Major Businesses
Table 119. PerkinElmer Peptide Nucleic Acid Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. PerkinElmer Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. PerkinElmer Recent Development
Table 122. SciGene Corporation Corporation Information
Table 123. SciGene Corporation Description and Major Businesses
Table 124. SciGene Corporation Peptide Nucleic Acid Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. SciGene Corporation Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. SciGene Corporation Recent Development
Table 127. Roche NimbleGen Corporation Information
Table 128. Roche NimbleGen Description and Major Businesses
Table 129. Roche NimbleGen Peptide Nucleic Acid Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. Roche NimbleGen Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Roche NimbleGen Recent Development
Table 132. CytoTest Corporation Information
Table 133. CytoTest Description and Major Businesses
Table 134. CytoTest Peptide Nucleic Acid Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. CytoTest Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. CytoTest Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Peptide Nucleic Acid Distributors List
Table 140. Peptide Nucleic Acid Customers List
Table 141. Peptide Nucleic Acid Market Trends
Table 142. Peptide Nucleic Acid Market Drivers
Table 143. Peptide Nucleic Acid Market Challenges
Table 144. Peptide Nucleic Acid Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Nucleic Acid Product Picture
Figure 2. Global Peptide Nucleic Acid Market Share by Type in 2021 & 2028
Figure 3. Double Chain Product Picture
Figure 4. Single Chain Product Picture
Figure 5. Global Peptide Nucleic Acid Market Share by Application in 2021 & 2028
Figure 6. Gene Chip
Figure 7. Electrophoresis
Figure 8. Fluorescence In Situ Hybridization
Figure 9. Peptide Nucleic Acid Report Years Considered
Figure 10. Global Peptide Nucleic Acid Capacity, Production and Utilization (2017-2028) & (K MT)
Figure 11. Global Peptide Nucleic Acid Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Peptide Nucleic Acid Production Market Share by Region (2017-2022)
Figure 13. Global Peptide Nucleic Acid Production Market Share by Region (2023-2028)
Figure 14. Peptide Nucleic Acid Production Growth Rate in North America (2017-2028) & (K MT)
Figure 15. Peptide Nucleic Acid Production Growth Rate in Europe (2017-2028) & (K MT)
Figure 16. Peptide Nucleic Acid Production Growth Rate in China (2017-2028) & (K MT)
Figure 17. Peptide Nucleic Acid Production Growth Rate in Japan (2017-2028) & (K MT)
Figure 18. Global Peptide Nucleic Acid Sales 2017-2028 (K MT)
Figure 19. Global Peptide Nucleic Acid Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Peptide Nucleic Acid Revenue 2017-2028 (US$ Million)
Figure 21. Global Peptide Nucleic Acid Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global Peptide Nucleic Acid Sales Market Share by Region (2017-2022)
Figure 23. Global Peptide Nucleic Acid Sales Market Share by Region (2023-2028)
Figure 24. North America Peptide Nucleic Acid Sales YoY (2017-2028) & (K MT)
Figure 25. North America Peptide Nucleic Acid Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe Peptide Nucleic Acid Sales YoY (2017-2028) & (K MT)
Figure 27. Europe Peptide Nucleic Acid Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Peptide Nucleic Acid Sales YoY (2017-2028) & (K MT)
Figure 29. Asia-Pacific Peptide Nucleic Acid Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America Peptide Nucleic Acid Sales YoY (2017-2028) & (K MT)
Figure 31. Latin America Peptide Nucleic Acid Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa Peptide Nucleic Acid Sales YoY (2017-2028) & (K MT)
Figure 33. Middle East & Africa Peptide Nucleic Acid Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The Peptide Nucleic Acid Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of Peptide Nucleic Acid in the World: Market Share by Peptide Nucleic Acid Revenue in 2021
Figure 36. Peptide Nucleic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global Peptide Nucleic Acid Sales Market Share by Type (2017-2028)
Figure 38. Global Peptide Nucleic Acid Revenue Market Share by Type (2017-2028)
Figure 39. Global Peptide Nucleic Acid Sales Market Share by Application (2017-2028)
Figure 40. Global Peptide Nucleic Acid Revenue Market Share by Application (2017-2028)
Figure 41. North America Peptide Nucleic Acid Sales Market Share by Type (2017-2028)
Figure 42. North America Peptide Nucleic Acid Revenue Market Share by Type (2017-2028)
Figure 43. North America Peptide Nucleic Acid Sales Market Share by Application (2017-2028)
Figure 44. North America Peptide Nucleic Acid Revenue Market Share by Application (2017-2028)
Figure 45. North America Peptide Nucleic Acid Sales Share by Country (2017-2028)
Figure 46. North America Peptide Nucleic Acid Revenue Share by Country (2017-2028)
Figure 47. U.S. Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 48. Canada Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 49. Europe Peptide Nucleic Acid Sales Market Share by Type (2017-2028)
Figure 50. Europe Peptide Nucleic Acid Revenue Market Share by Type (2017-2028)
Figure 51. Europe Peptide Nucleic Acid Sales Market Share by Application (2017-2028)
Figure 52. Europe Peptide Nucleic Acid Revenue Market Share by Application (2017-2028)
Figure 53. Europe Peptide Nucleic Acid Sales Share by Country (2017-2028)
Figure 54. Europe Peptide Nucleic Acid Revenue Share by Country (2017-2028)
Figure 55. Germany Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 56. France Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 58. Italy Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 59. Russia Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific Peptide Nucleic Acid Sales Market Share by Type (2017-2028)
Figure 61. Asia Pacific Peptide Nucleic Acid Revenue Market Share by Type (2017-2028)
Figure 62. Asia Pacific Peptide Nucleic Acid Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific Peptide Nucleic Acid Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific Peptide Nucleic Acid Sales Share by Region (2017-2028)
Figure 65. Asia Pacific Peptide Nucleic Acid Revenue Share by Region (2017-2028)
Figure 66. China Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 67. Japan Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 69. India Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 70. Australia Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 71. Taiwan Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 75. Philippines Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 76. Latin America Peptide Nucleic Acid Sales Market Share by Type (2017-2028)
Figure 77. Latin America Peptide Nucleic Acid Revenue Market Share by Type (2017-2028)
Figure 78. Latin America Peptide Nucleic Acid Sales Market Share by Application (2017-2028)
Figure 79. Latin America Peptide Nucleic Acid Revenue Market Share by Application (2017-2028)
Figure 80. Latin America Peptide Nucleic Acid Sales Share by Country (2017-2028)
Figure 81. Latin America Peptide Nucleic Acid Revenue Share by Country (2017-2028)
Figure 82. Mexico Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 83. Brazil Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 84. Argentina Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 85. Middle East and Africa Peptide Nucleic Acid Sales Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Peptide Nucleic Acid Revenue Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Peptide Nucleic Acid Sales Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Peptide Nucleic Acid Revenue Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Peptide Nucleic Acid Sales Share by Country (2017-2028)
Figure 90. Middle East and Africa Peptide Nucleic Acid Revenue Share by Country (2017-2028)
Figure 91. Turkey Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 92. Saudi Arabia Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 93. U.A.E Peptide Nucleic Acid Revenue (2017-2028) & (US$ Million)
Figure 94. Peptide Nucleic Acid Value Chain
Figure 95. Peptide Nucleic Acid Production Process
Figure 96. Channels of Distribution
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed

---